570 related articles for article (PubMed ID: 24263165)
1. Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam.
Zalts R; Neuberger A; Hussein K; Raz-Pasteur A; Geffen Y; Mashiach T; Finkelstein R
Am J Ther; 2016; 23(1):e78-85. PubMed ID: 24263165
[TBL] [Abstract][Full Text] [Related]
2. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
Yilmaz GR; Guven T; Guner R; Kocak Tufan Z; Izdes S; Tasyaran MA; Acikgoz ZC
J Infect Dev Ctries; 2015 May; 9(5):476-85. PubMed ID: 25989167
[TBL] [Abstract][Full Text] [Related]
3. Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study.
Assimakopoulos SF; Karamouzos V; Lefkaditi A; Sklavou C; Kolonitsiou F; Christofidou M; Fligou F; Gogos C; Marangos M
Infez Med; 2019 Mar; 27(1):11-16. PubMed ID: 30882373
[TBL] [Abstract][Full Text] [Related]
4. Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
Khalili H; Shojaei L; Mohammadi M; Beigmohammadi MT; Abdollahi A; Doomanlou M
J Comp Eff Res; 2018 Sep; 7(9):901-911. PubMed ID: 30192166
[TBL] [Abstract][Full Text] [Related]
5. Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience.
Russo A; Gullì SP; D'Avino A; Borrazzo C; Carannante N; Dezza FC; Covino S; Polistina G; Fiorentino G; Trecarichi EM; Mastroianni CM; Torti C; Oliva A
Int J Antimicrob Agents; 2024 Jul; 64(1):107190. PubMed ID: 38697579
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE
J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431
[TBL] [Abstract][Full Text] [Related]
7. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Qureshi ZA; Hittle LE; O'Hara JA; Rivera JI; Syed A; Shields RK; Pasculle AW; Ernst RK; Doi Y
Clin Infect Dis; 2015 May; 60(9):1295-303. PubMed ID: 25632010
[TBL] [Abstract][Full Text] [Related]
8. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
[TBL] [Abstract][Full Text] [Related]
9. Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
Kalin G; Alp E; Akin A; Coskun R; Doganay M
Infection; 2014 Feb; 42(1):37-42. PubMed ID: 23828559
[TBL] [Abstract][Full Text] [Related]
10. Management of ventilator associated pneumonia with a new antibiotic adjuvant entity (ceftriaxone+sulbactam+disodium edetate) - A novel approach to spare carbapenems.
Sathe P; Maddani S; Kulkarni S; Munshi N
J Crit Care; 2017 Oct; 41():145-149. PubMed ID: 28535440
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of extended-infusion of carbapenem plus sulbactam for ventilator-associated pneumonia caused by extensive drug-resistant
Wang X; Hu Y; Que CL; Zhang H; Huang JJ; Cao J; Jin Z; Wang GF; Zhang W
Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(38):2996-3000. PubMed ID: 29061006
[No Abstract] [Full Text] [Related]
12. Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.
Hiraki Y; Yoshida M; Masuda Y; Inoue D; Tsuji Y; Kamimura H; Karube Y; Takaki K; Kawano F
Int J Infect Dis; 2013 Dec; 17(12):e1234-6. PubMed ID: 23791858
[TBL] [Abstract][Full Text] [Related]
13. High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii.
Betrosian AP; Frantzeskaki F; Xanthaki A; Georgiadis G
Scand J Infect Dis; 2007; 39(1):38-43. PubMed ID: 17366011
[TBL] [Abstract][Full Text] [Related]
14. Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin.
Álvarez-Marín R; López-Rojas R; Márquez JA; Gómez MJ; Molina J; Cisneros JM; Ortiz-Leyba C; Aznar J; Garnacho-Montero J; Pachón J
PLoS One; 2016; 11(12):e0168468. PubMed ID: 27992528
[TBL] [Abstract][Full Text] [Related]
15. Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Raz-Pasteur A; Liron Y; Amir-Ronen R; Abdelgani S; Ohanyan A; Geffen Y; Paul M
J Glob Antimicrob Resist; 2019 Jun; 17():168-172. PubMed ID: 30557685
[TBL] [Abstract][Full Text] [Related]
16. Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Lin HS; Lee MH; Cheng CW; Hsu PC; Leu HS; Huang CT; Ye JJ
Infect Dis (Lond); 2015 Jun; 47(6):370-8. PubMed ID: 25746600
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial treatment and clinical outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia.
Chan JD; Graves JA; Dellit TH
J Intensive Care Med; 2010; 25(6):343-8. PubMed ID: 20837632
[TBL] [Abstract][Full Text] [Related]
19. In vitro Activity of Colistin in Combination with Tigecycline against Carbapenem-Resistant Acinetobacter baumannii Strains Isolated from Patients with Ventilator-Associated Pneumonia.
Cikman A; Gulhan B; Aydin M; Ceylan MR; Parlak M; Karakecili F; Karagoz A
Int J Med Sci; 2015; 12(9):695-700. PubMed ID: 26392806
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
